Remains on track to name a development candidate for a novel first-in-class neurology program targeting demyelinating diseases in 2026Progresses discovery work on a best-in-class cell therapeutic ...
From January 16th to 18th, the event you need to attend, arrives in Miami to help you execute the 2026 you want to achieve. A ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback